Physician profile
Shane Nau
NPI 1861952285
$1,514.16
in general payments reported to CMS, 2019-2025
13 companies · $593 in 2025
The $593 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $132 · 2024: $789 · 2025: $593.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,514.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,514.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $462.14 | 2024-2025 | Omni Surgical System, Sion Surgical Instrument |
| Alcon Vision LLC | $369.94 | 2023-2025 | Clareon, Tryptyr, Hydrus Microstent |
| New World Medical,INC. | $176.74 | 2025 | Kahook Dual Blade, Via360, Clearpath |
| Regeneron Healthcare Solutions, INC. | $165.55 | 2024-2025 | Eylea Hd |
| Sun Pharmaceutical Industries INC. | $140.67 | 2024 | |
| Harrow Eye, LLC | $36.29 | 2024 | Vevye |
| Johnson & Johnson Surgical Vision, INC. | $33.73 | 2023-2024 | Tecnis Simplicity, Tecnis Iol |
| Tarsus Pharmaceuticals, INC. | $26.61 | 2024 | Xdemvy |
| Rxsight INC | $24.89 | 2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Dompe US, INC. | $24.51 | 2024 | Oxervate |
| Apellis Pharmaceuticals, INC. | $23.22 | 2023 | Syfovre |
| Thea Pharma INC. | $15.09 | 2023 | Iyuzeh |
| Abbvie INC. | $14.78 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shane Nau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.